Agilon Health (AGL) Projected to Post Quarterly Earnings on Tuesday

Key Points

• Agilon Health (AGL) is expected to release its Q2 2025 earnings on August 5th, with analysts anticipating earnings of ($0.11) per share and revenue of $1.47 billion.
• In the previous quarter, Agilon Health reported a revenue of $1.53 billion, exceeding expectations, but experienced a 4.5% year-over-year decline.
• Agilon Health's stock has seen a 3.4% drop and currently trades at $1.99, significantly below its 1-year high of $7.62.

Agilon Health (NYSE:AGL - Get Free Report) will likely be announcing its Q2 2025 earnings results after the market closes on Tuesday, August 5th. Analysts expect the company to announce earnings of ($0.11) per share and revenue of $1.47 billion for the quarter. Agilon Health has set its FY 2025 guidance at EPS and its Q2 2025 guidance at EPS.

Agilon Health (NYSE:AGL - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.03 EPS for the quarter, beating analysts' consensus estimates of ($0.01) by $0.04. Agilon Health had a negative net margin of 4.04% and a negative return on equity of 45.47%. The company had revenue of $1.53 billion for the quarter, compared to analysts' expectations of $1.50 billion. During the same quarter in the prior year, the company posted ($0.02) earnings per share. Agilon Health's revenue for the quarter was down 4.5% compared to the same quarter last year. On average, analysts expect Agilon Health to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Agilon Health Trading Down 1.8%

NYSE AGL traded down $0.04 during trading hours on Wednesday, reaching $1.90. The company had a trading volume of 3,137,863 shares, compared to its average volume of 5,032,556. The stock has a 50-day moving average of $2.22 and a 200 day moving average of $3.24. Agilon Health has a 1-year low of $1.50 and a 1-year high of $7.53. The stock has a market capitalization of $784.44 million, a P/E ratio of -3.21 and a beta of 0.16.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the stock. Barclays increased their price target on shares of Agilon Health from $2.00 to $3.00 and gave the stock an "underweight" rating in a research report on Thursday, May 8th. TD Cowen raised their price objective on shares of Agilon Health from $3.50 to $6.00 and gave the company a "hold" rating in a research note on Tuesday, April 15th. Cowen reissued a "hold" rating on shares of Agilon Health in a research note on Tuesday, April 15th. Wells Fargo & Company lowered their price objective on shares of Agilon Health from $6.00 to $5.00 and set an "overweight" rating for the company in a research note on Tuesday, May 13th. Finally, Sanford C. Bernstein raised shares of Agilon Health from a "market perform" rating to an "outperform" rating and raised their price objective for the company from $3.30 to $8.50 in a research note on Tuesday, April 8th. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, Agilon Health presently has an average rating of "Hold" and an average target price of $4.71.

Institutional Trading of Agilon Health

Institutional investors and hedge funds have recently bought and sold shares of the business. Dynamic Technology Lab Private Ltd increased its position in Agilon Health by 28.4% during the 1st quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company's stock worth $204,000 after purchasing an additional 10,424 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Agilon Health by 3.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,200 shares of the company's stock worth $927,000 after acquiring an additional 7,209 shares during the period. AQR Capital Management LLC boosted its holdings in Agilon Health by 243.3% in the 1st quarter. AQR Capital Management LLC now owns 501,440 shares of the company's stock worth $2,171,000 after acquiring an additional 355,365 shares during the period. Finally, Goldman Sachs Group Inc. boosted its holdings in Agilon Health by 6.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 5,060,333 shares of the company's stock worth $21,911,000 after acquiring an additional 311,158 shares during the period.

Agilon Health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.